Why the study?
Can [(11)C]NNC 112 PET imaging quantify D1-like receptors in the renal cortex of rats and primates in vivo?
Can [(11)C]NNC 112 PET imaging quantify D1-like receptors in the renal cortex of rats and primates in vivo?
[(11)C]NNC 112 PET imaging can successfully quantify renal dopamine D1-like receptors in vivo in animal models, providing a tool for future human studies in hypertension and kidney disease.
Answers are grounded in this paper and cite their sources.
Should not change clinical practice; leaves open human translation of renal D1-like receptor PET imaging in hypertension.
The intrarenal dopamine system is important for signaling and natriuresis, and significant dysfunction is associated with hypertension and kidney disease in ex vivo studies. Dopamine receptors also modulate and are modulated by the renin-angiotensin-aldosterone system. Here, we show the first in vivo measurement of D1-like receptors in the renal cortex of Sprague-Dawley rat and Papio anubis baboon using [(11)C]NNC 112, a positron emission tomography radioligand for D1-like receptors. In addition, we show a D1-like binding potential response to angiotensin II blockade in rats using losartan. Demonstration of self-saturable binding in the rat as well as specific and saturable binding in Papio anubis validate the use of [(11)C]NNC 112 in the first in vivo measurement of renal dopamine D1-like receptors. Furthermore, [(11)C]NNC 112 is a radioligand tool already validated for use in probing human central nervous system (CNS) D1-like receptors. Our work demonstrates specific and saturable non-CNS binding in higher animals and the ability to quantify physiological response to drug treatment and provides a clear path to extend use of [(11)C]NNC 112 to study renal dopamine in humans.
No takes yet. Share an insight, caveat, or question.
Granda et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: